This is the authors' abstract. We don't add key points for this paper.
In 2024, there have been increases in laboratory-confirmed infections caused by Mycoplasma pneumoniae worldwide. This case series highlights the increasing frequency of M. pneumoniae-positive PCR (polymerase chain reaction) specimens and an increased number of hospital admissions with M. pneumoniae clinical syndromes. Within this case series, we observed a change in the epidemiology and clinical burden of childhood M. pneumoniae disease in the post-COVID-19 era.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
McCarthy et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: